Output:

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.

The study further noted that the treatment was effective in reducing the severity of clinical symptoms and improving the overall health of patients. The results indicated that traditional Chinese medicine could play an important role in treating pulmonary tuberculosis by boosting cellular immunity and alleviating clinical symptoms. The study also suggested that the treatment could be used as part of a comprehensive approach to managing pulmonary tuberculosis, combining traditional Chinese medicine with conventional Western medicine.

In addition, the study highlighted the importance of early diagnosis and treatment in preventing the progression of pulmonary tuberculosis. It emphasized the need for timely intervention to prevent complications such as brain damage and other serious health issues associated with pulmonary tuberculosis.

Overall, the study provided valuable insights into the potential benefits of traditional Chinese medicine in treating pulmonary tuberculosis, offering a promising alternative or complementary treatment option for patients who may not respond well to conventional Western medicine.

Output: Related. To explore the relationship between pulmonary tuberculosis and cellular immunity, we measured mediated cytotoxicity (CMC) in patients with infiltrative pulmonary tuberculosis and analyzed the dynamic changes before and after treatment for yin deficiency syndrome in pulmonary tuberculosis. All patients in this group with yin deficiency were treated with Xuan Shen, Sha Shen, Mai Dong, Bai Bu, Huang Jing, and Lu Han medicinal herbs. The results showed that 56 cases were lower than the normal group (p<0.01); 31 cases of patients with yin deficiency syndrome in this disease experienced improvement in their CMC levels after traditional Chinese medicine treatment. After treatment, the average CMC values were significantly lower compared to the normal group, indicating that traditional Chinese medicine could enhance the body's cellular immunity and improve clinical symptoms. The study also found that the treatment had a positive effect on improving the patient's overall condition, with significant improvements observed in CMC levels as well. The research concluded that traditional Chinese medicine could effectively treat this disease by boosting cellular immunity and alleviating clinical symptoms.